CIO Influence
CIO Influence News Robots

CARTI Selects Accuray CyberKnife S7 System to Increase Access to Advanced Cancer Care for Patients in Rural Communities Throughout Arkansas

CARTI Selects Accuray CyberKnife S7 System to Increase Access to Advanced Cancer Care for Patients in Rural Communities Throughout Arkansas
CARTI is First in Arkansas to Treat Patients with World’s Only Robotic Radiosurgery System

Accuray Incorporated announced that the CARTI medical care team in Little Rock, Arkansas has treated the first patients in the state using the Accuray CyberKnife® S7™ System. The entire CyberKnife procedure is typically completed in just 1 to 5 out-patient sessions, providing a shorter overall course of treatment compared to conventional radiation therapy which typically takes 30-40 sessions. The availability of the CyberKnife technology will enable the CARTI team to expand access to precise radiation therapy to patients throughout Arkansas, including those for whom a month or more of travel would have been a barrier to treatment.

Top iTechnology Automation News: NextGen Enterprise Earns ONC Health IT C**** Update Certification

“Accuray is proud to partner with the CARTI team and support their efforts to improve cancer care in Arkansas. Both organizations share the belief that access to advanced technology can make living longer, better lives a reality for more patients,” said Suzanne Winter, president at Accuray. “Accuray has a history of innovation resulting in powerful and flexible options that enable our customers to make precise radiation treatments available to more patients. The CyberKnife S7 System, the latest generation CyberKnife platform, demonstrates our focus on providing clinically relevant, forward-looking technology designed to change patients’ lives for the better.”

The CyberKnife platform specializes in delivering stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT), advanced external beam radiation treatment techniques. The CyberKnife S7 System was designed to provide clinicians with the speed they need for operational efficiency, without sacrificing the precision and accuracy required for SRS and SBRT. Patients who undergo SRS and SBRT treatments receive a higher dose of radiation per session across fewer total sessions (hypofractionated radiation therapy) than patients who receive conventional radiation therapy, leading to less disruption of their daily lives.

“We are thrilled to be the only provider in Arkansas to offer patients superior radiation oncology care with the CyberKnife System,” said Adam Head, president and CEO of the statewide cancer care provider. “In our mission to provide the most leading-edge treatment options, we’ve expanded our radiation oncology department to include the CyberKnife S7 System, the only robotic radiosurgery system. With this technology, we can confidently deliver precise, highly effective radiation treatments without sacrificing delivery speed or patient comfort. This marks a new phase of radiation oncology care in Arkansas, and we’re excited to be at the forefront.”

Top iTechnology Cloud News: Deloitte Consulting Completes Acquisition of BIAS Corporation

“Today, there are more options than ever to treat tumors located in almost any area of the body,” said Dr. Matthew Hardee, CARTI radiation oncologist and medical director of radiation oncology. “The CyberKnife System represents a significant leap forward as we can now efficiently and effectively treat a wider range of tumor types, including some that previously would have been untreatable with radiation.”

The CyberKnife Platform: Facilitating Better, Faster, Full-Body Radiation Treatments
The CyberKnife platform’s robotic design, in combination with Accuray-exclusive Synchrony® real-time target tracking with dynamic delivery technology, enables treatment of cancerous and benign tumors throughout the body, as well as neurologic disorders, with sub-millimeter precision. Synchrony® uses advanced algorithms and artificial intelligence (AI) to drive dynamic delivery, adapting for tumors that move as a result of bodily processes, including respiration and digestion, as well as patient movement – without uncomfortable patient restraints, breath-hold techniques, or interrupting treatment. The platform’s ability to automatically stay on target despite patient and tumor motion truly differentiates it from conventional radiation delivery systems.

Top iTechnology IOT News: Marvell Unveils Co-Packaged Optics Technology Platform at OFC 2022

[To share your insights with us, please write to sghosh@martechseries.com]

Related posts

Newell Brands Announces Agreement to Sell the Connected Home & Security Business to Resideo Technologies, Inc.

CIO Influence News Desk

Miramar Group Leverages Customer Data with SAP Emarsys to Power Up Customer Journey

PR Newswire

MCCI Unveils Revolutionary Tanager Product, Empowering the Industry with Cutting-Edge Video Analysis Technology

PR Newswire

Leave a Comment